FDA Approves Unknown Drug — FRESENIUS KABI USA

# FDA Approves Generic Drug for Fresenius Kabi USA Fresenius Kabi USA received FDA approval for a generic drug formulation under ANDA219991, expanding the company's portfolio in the competitive generic pharmaceutical market and potentially capturing additional market share as healthcare providers seek cost-effective treatment alternatives. The approval positions Fresenius Kabi to capitalize on growing demand for generic medications while strengthening its position as a key supplier in the biosimilar and generic drug landscape.